LONG-TERM LEASE AGREEMENTLong-Term Lease Agreement • August 14th, 2019 • Viela Bio, Inc. • Pharmaceutical preparations • Maryland
THIS LONG-TERM LEASE AGREEMENT (this “Lease”) is made as of June 30, 2018 (“Effective Date”), by and between MedImmune, LLC a Delaware limited liability company (“Landlord”), and Viela Bio, Inc., a Delaware corporation (“Tenant”).
BIOWA SUBLICENSE AGREEMENT between MEDIMMUNE, LLC. and VIELA BIO, INC. Dated as of February 23, 2018Sublicense Agreement • August 14th, 2019 • Viela Bio, Inc. • Pharmaceutical preparations • New York
This BioWa Sublicense Agreement (this “Agreement”) is made and entered into as of February 23, 2018 (the “Effective Date”) by and between MedImmune, LLC, a Delaware corporation, whose registered office is at One MedImmune Way, Gaithersburg, Maryland 20878 (and which is a member of the AstraZeneca group of companies) (“MedImmune”) and Viela Bio, Inc., a Delaware corporation (“Spinco”). MedImmune and Spinco are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENT between MEDIMMUNE, LLC and VIELA BIO, INC. Dated as of February 23, 2018License Agreement • August 14th, 2019 • Viela Bio, Inc. • Pharmaceutical preparations • New York
This License Agreement (this “Agreement”) is made and entered into as of February 23, 2018 (the “Effective Date”) by and between MedImmune, LLC, a Delaware corporation (and a member of the AstraZeneca group of companies) (“MedImmune”) and Viela Bio, Inc., a Delaware corporation (“Spinco”). MedImmune and Spinco are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
TRANSITION SERVICES AGREEMENT BY AND BETWEEN MEDIMMUNE, LLC, AND VIELA BIO, INC. DATED AS OF FEBRUARY 23, 2018Transition Services Agreement • August 14th, 2019 • Viela Bio, Inc. • Pharmaceutical preparations • New York
TRANSITION SERVICES AGREEMENT (this “Agreement”) dated as of February 23, 2018 (the “Effective Date”), between MEDIMMUNE, LLC, a Delaware limited liability company (“AZ”), and Viela Bio, Inc., a Delaware corporation (“Spinco”). AZ and Spinco are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
CLINICAL SUPPLY AGREEMENT by and between ASTRAZENECA UK LIMITED and VIELA BIO, INC. DATED AS OF FEBRUARY 23, 2018Clinical Supply Agreement • August 14th, 2019 • Viela Bio, Inc. • Pharmaceutical preparations • New York
[*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
